CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-24 | GRIFFITH MELINDA Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | GRIFFITH MELINDA Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-06-24 | Arno Andrew Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2021-06-24 | Arno Andrew Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2021-06-11 | Last Andrew J. Director | Option exercise | +6,993 | $3.00 | $21K | 30,170 |
| 2021-06-11 | Last Andrew J. Director | Option exercise · Warrants | +6,993 | 0 | ||
| 2021-05-07 | ANDREWS RONALD ASBURY Chief Executive Officer | Option exercise | +106,221 | 219,919 | ||
| 2021-05-07 | ANDREWS RONALD ASBURY Chief Executive Officer | Option exercise · Restricted Stock Units | −106,221 | 0 | ||
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Option exercise | +20,000 | 66,700 | ||
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Shares withheld for taxes | −4,620 | 62,080 | ||
| 2021-04-28 | Levine Mitchell S Chief Financial Officer | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2021-03-19 | ANDREWS RONALD ASBURY Chief Executive Officer | Purchase | +11,000 | $4.79 | $53K | 113,698 |
| 2021-02-25 | Sundar Padmavathi Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +255,000 | $5.34 | $1.4M | 255,000 |
| 2021-02-25 | Levine Mitchell S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +255,000 | $5.34 | $1.4M | 255,000 |
| 2021-02-25 | ANDREWS RONALD ASBURY Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +500,000 | $5.34 | $2.7M | 500,000 |
| 2021-02-25 | Ross Douglas T. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +255,000 | $5.34 | $1.4M | 255,000 |
| 2021-02-05 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +600,000 | $4.50 | $2.7M | 16,776,484 |
| 2021-02-05 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 16,776,484 | ||
| 2021-01-20 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +1,460,280 | $3.42 | $5.0M | 16,176,484 |
| 2021-01-20 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 16,176,484 |
Page 14 of 20 · 383 trades